In situ forming implants for local chemotherapy and hyperthermia of bone tumors

Journal of Drug Delivery Science and Technology

Volumn 22, Issue 5, 2012, Pages 393-408

  Mohamed, M ^a   Borchard, G ^a   Jordan, O ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Bone metastases; Cementoplasty; Chemotherapy; Drug delivery systems; In situ forming implants; Induced hyperthermia; Iron oxide nanoparticles; Vertebroplasty

Indexed keywords

ALGINIC ACID; BISPHENOL A BIS(2 HYDROXYPROPYL) ETHER DIMETHACRYLATE; CALCIUM PHOSPHATE; CALCIUM PHOSPHATE DIBASIC; CHITOSAN; CISPLATIN; DAUNORUBICIN; DOXORUBICIN; GENTAMICIN; GENTAMICIN BONE CEMENT; HEAT SHOCK PROTEIN; HYDROXYAPATITE; IRON OXIDE; METHOTREXATE; PACLITAXEL; PALACOS; PAMIDRONIC ACID; SUCCINIC ACID; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; TETRACALCIUM PHOSPHATE; UNCLASSIFIED DRUG; ZOLEDRONIC ACID;

BONE IMPLANT; BONE METASTASIS; BONE TUMOR; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; HEAT TOLERANCE; HUMAN; HYPERTHERMIC THERAPY; MAGNETIC FIELD; REVIEW; TUMOR MICROENVIRONMENT;

EID: 84868691970     PISSN: 17732247     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1773-2247(12)50066-3     Document Type: Review

References (232)

1. Ahmedin J. - Global cancer statistics. - CA. Cancer J. Clin., 61, 69-90, 2011.
2. Siegel R., Naishadham D., Jemal A. - Cancer statistics, 2012. - CA. Cancer J. Clin., 62, 10-29, 2012.
3. Waldmann T.A. - Immunotherapy: past, present and future. - Nat. Med., 9, 269-277, 2003.
4. Dougan M., Dranoff G. - Immune therapy for cancer. - Annu. Rev. Immunol., 27, 83-117, 2009.
5. Ingle J.N. - Hormonal therapy: current and new directions. - The Breast J., 9, S17-S21, 2003.
6. Firczuk M., Winiarska M., Szokalska A., Jodlowska M., Swiech M., Bojarczuk K., Salwa P., Nowis D. - Approaches to improve photodynamic therapy of cancer. - Front. Biosci., 16, 208-224, 2011.
7. Ruel-Gariépy E., Leroux J.-C. - In situ-forming hydrogels - review of temperature-sensitive systems. - Eur. J. Pharm. Biopharm., 58, 409-426, 2004.
8. Chen F.-A., Kuriakose M.A., Zhou M.-X., DeLacure M.D., Dunn R.L. - Biodegradable polymer-mediated intratumoral delivery of cisplatin for treatment of human head and neck squamous cell carcinoma in a chimeric mouse model. - Head Neck, 25, 554-560, 2003.
9. Jordan O., Rufenacht D.A., Iselin C., Doelker E. - Biomaterials for injectable therapeutic implants. - Chimia, 59, 353-356, 2005.
10. Shively M.L., Coonts B.A., Renner W.D., Southard J.L., Bennett A.T. - Physico-chemical characterization of a polymeric injectable implant delivery system. - J. Controlled Release, 33, 237-243, 1995.
11. Hatefi A., Amsden B. - Biodegradable injectable in situ forming drug delivery systems. - J. Controlled Release, 80, 9-28, 2002.
12. Eliaz R.E., Szoka F.C. - Robust and prolonged gene expression from injectable polymeric implants. - Gene Ther., 9, 1230-1237, 2002.
13. Exner A.A., Saidel G.M. - Drug-eluting polymer implants in cancer therapy. - Expert Opin. Drug Deliv., 5, 775-788, 2008.
14. Wadee A., Pillay V., Choonara Y.E., du T.L.C., Penny C., Ndesendo V.M.K., Kumar P., Murphy C.S. - Recent advances in the design of drug-loaded polymeric implants for the treatment of solid tumors. - Expert Opin. Drug Deliv., 8, 1323-1340, 2011.
15. Gutowska A., Jeong B., Jasionowski M. - Injectable gels for tissue engineering. - The Anat. Rec., 263, 342-349, 2001.
16. van der Zee J. - Heating the patient: a promising approach? - Ann. Oncol., 13, 1173-1184, 2002.
17. Fajardo L-G L.F. - Pathological effects of hyperthermia in normal tissues. - Cancer Res., 44, 4826s-4835s, 1984.
18. Stauffer P.R., Goldberg S.N. - Introduction: thermal ablation therapy. - Int. J. Hyperthermia, 20, 671-677, 2004.
19. Habash R.W.Y., Bansal R., Krewski D., Alhafid H.T. - Thermal therapy, part 3: ablation techniques. - Crit. Rev. Biomed. Eng., 35, 37-121, 2007.
20. Bruners P., Braunschweig T., Hodenius M., Pietsch H., Penzkofer T., Baumann M., Gunther R.W., Schmitz-Rode T., Mahnken A.H. - Thermoablation of malignant kidney tumors using magnetic nanoparticles: an in vivo feasibility study in a rabbit model. - Cardiovasc. Intervent. Radiol., 33, 127-134, 2010.
21. Hilger I., Hiergeist R., Hergt R., Winnefeld K., Schubert H., Kaiser W.A. - Thermal ablation of tumors using magnetic nanoparticles - an in vivo feasibility study. - Invest. Radiol., 37, 580-586, 2002.
22. Liapi E., Geschwind J.F.H. - Transcatheter and ablative therapeutic approaches for solid malignancies. - J. Clin. Oncol., 25, 978-986, 2007.
23. Moroz P., Jones S.K., Gray B.N. - Magnetically mediated hyperthermia: current status and future directions. - Int. J. Hyperthermia, 18, 267-284, 2002.
24. van der Zee J., González D., van Rhoon G.C., van Dijk J.D.P., van Putten W.L.J., Hart A.A.M. - Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. - The Lancet, 355, 1119-1125, 2000.
25. Falk M.H., Issels R.D. - Hyperthermia in oncology. - Int. J. Hyperthermia, 17, 1-18, 2001.
26. Wust P., Hildebrandt B., Sreenivasa G., Rau B., Gellermann J., Riess H., Felix R., Schlag P.M. - Hyperthermia in combined treatment of cancer. - Lancet Oncol., 3, 487-497, 2002.
27. Johannsen M., Gneveckow U., Eckelt L., Feussner A., Waldofner N., Scholz R., Deger S., Wust P., Loening S.A., Jordan A. - Clinical hyperthermia of prostate cancer using magnetic nanoparticles: presentation of a new interstitial technique. - Int. J. Hyperthermia, 21, 637-647, 2005.
28. Thiesen B., Jordan A. - Clinical applications of magnetic nanoparticles for hyperthermia. - Int. J. Hyperthermia, 24, 467-474, 2008.
29. Issels R.D. - Hyperthermia adds to chemotherapy. - Eur. J. Cancer, 44, 2546-2554, 2008.
30. Issels R.D., Lindner L.H., Verweij J., Wust P., Reichardt P., Schem B.C., Abdel-Rahman S., Daugaard S., Salat C., Wendtner C.M., Vujaskovic Z., Wessalowski R., Jauch K.W., Durr H.R., Ploner F., Baur-Melnyk A., Mansmann U., Hiddemann W., Blay J.Y., Hohenberger P. - Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study. - Lancet Oncol., 11, 561-570, 2010.
31. Habash R.W.Y., Bansal R., Krewski D., Alhafia H.T. - Thermal therapy, part 2: hyperthermia techniques. - Crit. Rev. Biomed. Eng., 34, 491-542, 2006.
32. Chichel A., Skowronek J., Kubaszewska M., Kanikowski M. - Hyperthermia - description of a method and a review of clinical applications. - Rep. Pract. Oncol. Radiother., 12, 267-275, 2007.
33. Habash R.W.Y., Krewski D., Bansal R., Alhafid H.T. - Principles, applications, risks and benefits of therapeutic hyperthermia. - Front. Biosci., E3, 1169-1181, 2011.
34. Stauffer P.R. - Evolving technology for thermal therapy of cancer. - Int. J. Hyperthermia, 21, 731-744, 2005.
35. Babincova M., Altanerova V., Altaner C., Cicmanec P., Babinec P. - In vivo heating of magnetic nanoparticles in alternating magnetic field. - Med. Phys., 31, 2219-2221, 2004.
36. Jordan A., Scholz R., Wust P., Fähling H., Krause J., Wlodarczyk W., Sander B., Vogl T., Felix R. - Effects of magnetic fluid hyperthermia (MFH) on C3H mammary carcinoma in vivo. - Int. J. Hyperthermia, 13, 587-605, 1997.
37. Johannsen M., Jordan A., Scholz R., Koch M., Lein M., Deger S., Roigas J., Jung K., Loening S. - Evaluation of magnetic fluid hyperthermia in a standard rat model of prostate cancer. - J. Endourol., 18, 495-500, 2004.
38. Johannsen M., Thiesen B., Jordan A., Taymoorian K., Gneveckow U., Waldofner N., Scholz R., Koch M., Lein M., Jung K., Loening S.A. - Magnetic fluid hyperthermia (MFH) reduces prostate cancer growth in the orthotopic dunning R3327 rat model. - Prostate, 64, 283-292, 2005.
39. Jordan A., Scholz R., Maier-Hauff K., van Landeghem F., Waldoefner N., Teichgraeber U., Pinkernelle J., Bruhn H., Neumann F., Thiesen B., von Deimling A., Felix R. - The effect of thermotherapy using magnetic nanoparticles on rat malignant glioma. - J. Neurooncol., 78, 7-14, 2006.
40. Le Renard P.E., Buchegger F., Petri-Fink A., Bosman F., Rufenacht D., Hofmann H., Doelker E., Jordan O. - Local moderate magnetically induced hyperthermia using an implant formed in situ in a mouse tumor model. - Int. J. Hyperthermia, 25, 229-239, 2009.
41. Le Renard P.E., Jordan O., Faes A., Petri-Fink A., Hofmann H., Rufenacht D., Bosman F., Buchegger F., Doelker E. - The in vivo performance of magnetic particle-loaded injectable, in situ gelling, carriers for the delivery of local hyperthermia. - Biomater., 31, 691-705, 2010.
42. Wust P., Gneveckow U., Johannsen M., Bohmer D., Henkel T., Kahmann F., Sehouli J., Felix R., Ricke J., Jordan A. - Magnetic nanoparticles for interstitial thermotherapy - feasibility, tolerance and achieved temperatures. - Int. J. Hyperthermia, 22, 673-685, 2006.
43. Johannsen M., Gneueckow U., Thiesen B., Taymoorian K., Cho C.H., Waldofner N., Scholz R., Jordan A., Loening S.A., Wust P. - Thermotherapy of prostate cancer using magnetic nanoparticles: feasibility, imaging, and three-dimensional temperature distribution. - Eur. Urol., 52, 1653-1662, 2007.
44. Maier-Hauff K., Rothe R., Scholz R., Gneveckow U., Wust P., Thiesen B., Feussner A., von Deimling A., Waldoefner N., Felix R., Jordan A. - Intracranial thermotherapy using magnetic nanoparticles combined with external beam radiotherapy: results of a feasibility study on patients with glioblastoma multiforme. - J. Neurooncol., 81, 53-60, 2007.
45. Mahmoudi M., Hofmann H., Rothen-Rutishauser B., Petri-Fink A. - Assessing the in vitro and in vivo toxicity of superparamagnetic iron oxide nanoparticles. - Chem. Rev., ahead of print, 2011.
46. Pankhurst Q.A., Connolly J., Jones S.K., Dobson J. - Applications of magnetic nanoparticles in biomedicine. - J. Phys. D Appl. Phys., 36, R167-R181, 2003.
47. Le Renard P.E., Lortz R., Senatore C., Rapin J.P., Buchegger F., Petri-Fink A., Hofmann H., Doelker E., Jordan O. - Magnetic and in vitro heating properties of implants formed in situ from Injectable formulations and containing superparamagnetic iron oxide nanoparticles (SPIONs) embedded in silica microparticles for magnetically induced local hyperthermia. - J. Magn. Magn. Mater., 323, 1054-1063, 2011.
48. Mundy G.R. - Metastasis to bone: causes, consequences and therapeutic opportunities. - Nat. Rev. Cancer, 2, 584-593, 2002.
49. Weilbaecher K.N., Guise T.A., McCauley L.K. - Cancer to bone: a fatal attraction. - Nat. Rev. Cancer, 11, 411-425, 2011.
50. Yoneda T., Hiraga T. - Crosstalk between cancer cells and bone microenvironment in bone metastasis. - Biochem. Biophys. Res. Commun., 328, 679-687, 2005.
51. Rubens R.D. - Bone metastases - the clinical problem. - Eur. J. Cancer, 34, 210-213, 1998.
52. Maisano R., Pergolizzi S., Cascinu S. - Novel therapeutic approaches to cancer patients with bone metastasis. - Crit. Rev. Oncol. Hematol., 40, 239-250, 2001.
53. Harrington K.D. - Metastatic disease of the spine. - J. Bone Joint Surg. Am., 68A, 1110-1115, 1986.
54. Coleman R.E. - Clinical features of metastatic bone disease and risk of skeletal morbidity. - Clin. Cancer Res., 12, 6243S-6249S, 2006.
55. Heary R.F., Bono C.M. - Metastatic spinal tumors. - Neurosurg. Focus, 11, 1-9, 2001.
56. Casimiro S., Guise T.A., Chirgwin J. - The critical role of the bone microenvironment in cancer metastases. - Mol. Cell. Endocrinol., 310, 71-81, 2009.
57. Pockett R.D., Castellano D., McEwan P., Oglesby A., Barber B.L., Chung K. - The hospital burden of disease associated with bone metastases and skeletal-related events in patients with breast cancer, lung cancer, or prostate cancer in Spain. - Eur. J. Cancer Care, 19, 755-760, 2009.
58. Bickels J., Dadia S., Lidar Z. - Surgical management of metastatic bone disease. - J. Bone Joint Surg. Am., 91A, 1503-1516, 2009.
59. Weber K.L., Gebhardt M.C. - What's new in musculoskeletal oncology. - J. Bone Joint Surg. Am., 85A, 761-767, 2003.
60. Msaouel P., Pissimissis N., Halapas A., Koutsilieris M. - Mechanisms of bone metastasis in prostate cancer: clinical implications. - Best Pract. & Res. Clin. Endocrinol. & Metab., 22, 341-355, 2008.
61. Chiras J., Barragan-Campos H.M., Cormier E., Jean B., Rose M., LeJean L. - Vertebroplasty: state of the art. - J. Radiol., 88, 1255-1260, 2007.
62. Wenger M. - Vertebroplasty for metastasis. - Med. Oncol., 20, 203-209, 2003.
63. San Millan Ruiz D., Burkhardt K., Jean B., Muster M., Martin J.B., Bouvier J., Fasel J.H.D., Rüfenacht D.A., Kurt A.M. - Pathology findings with acrylic implants. - Bone, 25, 85S-90S, 1999.
64. Dewhirst M.W., Viglianti B.L., Lora-Michiels M., Hanson M., Hoopes P.J. - Basic principles of thermal dosimetry and thermal thresholds for tissue damage from hyperthermia. - Int. J. Hyperthermia, 19, 267-294, 2003.
65. Hildebrandt B., Wust P., Ahlers O., Dieing A., Sreenivasa G., Kerner T., Felix R., Riess H. - The cellular and molecular basis of hyperthermia. - Crit. Rev. Oncol. Hematol., 43, 33-56, 2002.
66. Dewey W.C. - Arrhenius relationships from the molecule and cell to the clinic. - Int. J. Hyperthermia, 25, 3-20, 2009.
67. Harmon B.V., Corder A.M., Collins R.J., Gobe G.C., Allen J., Allan D.J., Kerr J.F.R. - Cell death induced in a murine mastocytoma by 42-47°C heating in vitro: evidence that the form of death changes from apoptosis to necrosis above a critical heat load. - Int. J. Radiat. Biol., 58, 845-858, 1990.
68. Bodey B., Kaiser H.E. - Apoptosis in the mammalian thymus during normal histogenesis and under various in vitro and in vivo experimental conditions. - In vivo, 12, 123-133, 1998.
69. Esposti M.D., Dive C. - Mitochondrial membrane permeabilisation by Bax/Bak. - Biochem. Biophys. Res. Commun., 304, 455-461, 2003.
70. Luo X., Budihardjo I., Zou H., Slaughter C., Wang X. - Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. - Cell, 94, 481-490, 1998.
71. White E. - Life, death, and the pursuit of apoptosis. - Genes Dev., 10, 1-15, 1996.
72. Wang L., Du F., Wang X. - TNF-α induces two distinct caspase-8 activation pathways. - Cell, 133, 693-703, 2008.
73. Ulukaya E., Acilan C., Yilmaz Y. - Apoptosis: why and how does it occur in biology? - Cell Biochem. Funct., 29, 468-480, 2011.
74. Furusawa Y., Tabuchi Y., Takasaki I., Wada S., Ohtsuka K., Kondo T. - Gene networks involved in apoptosis induced by hyperthermia in human lymphoma U937 cells. - Cell Biol. Int., 33, 1253-1262, 2009.
75. Katschinski D.M., Robins H.I., Schad M., Frede S., Fandrey J. - Role of tumor necrosis factor alpha in hyperthermia-induced apoptosis of human leukemia cells. - Cancer Res., 59, 3404-3410, 1999.
76. Abe T.T., Y. Ono, A. H. Salker, K. Akiyama, T. Ohmoto, T. - Accumulation of cell cycle regulatory proteins, p21 and p27, induced after hyperthermia in human glioma cells. - Int. J. Hyperthermia, 17, 499-507, 2001.
77. Fuse T., Yoon K.W., Kato T., Yamada K. - Heat-induced apoptosis in human glioblastoma cell line A172. - Neurosurg., 42, 843-849, 1998.
78. Nakano K.K., M. Okamoto, S. Tone, K. Shinohara H. - Heat-induced apoptosis and p53 in cultured mammalian cells. - Int. J. Radiat. Biol., 71, 519-529, 1997.
79. Fukami T., Nakasu S., Baba K., Nakajima M., Matsuda M. - Hyperthermia induces translocation of apoptosis-inducing factor (AIF) and apoptosis in human glioma cell lines. - J. Neurooncol., 70, 319-331, 2004.
80. Arancia G., Trovalusci P.C., Mariutti G., Mondovi B. - Ultrastructural changes induced by hyperthermia in chinese hamster V79 fibroblasts. - Int. J. Hyperthermia, 5, 341-350, 1989.
81. Welch W.J., Suhan J.P. - Morphological study of the mammalian stress response: characterization of changes in cytoplasmic organelles, cytoskeleton, and nucleoli, and appearance of intranuclear actin filaments in rat fibroblasts after heat-shock treatment. - J. Cell Biol., 101, 1198-1211, 1985.
82. Coss R.A., Linnemans W.A.M. - The effects of hyperthermia on the cytoskeleton: a review. - Int. J. Hyperthermia, 12, 173-196, 1996.
83. Borrelli M.J., Wong R.S.L., Dewey W.C. - A direct correlation between hyperthermia-induced membrane blebbing and survival in synchronous G1 CHO cells. - J. Cell. Physiol., 126, 181-190, 1986.
84. Luchetti F., Mannello F., Canonico B., Battistelli M., Burattini S., Falcieri E., Papa S. - Integrin and cytoskeleton behaviour in human neuroblastoma cells during hyperthermia-related apoptosis. - Apoptosis, 9, 635-648, 2004.
85. Luchetti F., Canonico B., Della Felice M., Burattini S., Battistelli M., Papa S., Falcieri E. - Hyperthermia triggers apoptosis and affects cell adhesiveness in human neuroblastoma cells. - Histol. Histopathol., 18, 1041-1052, 2003.
86. Hayat H., Friedberg I. - Heat-induced alterations in cell membrane permeability and cell inactivation of transformed mouse fibroblasts. - Int. J. Hyperthermia, 2, 369-378, 1986.
87. Bischof J.C., Padanilam J., Holmes W.H., Ezzell R.M., Lee R.C., Tompkins R.G., Yarmush M.L., Toner M. - Dynamics of cell membrane permeability changes at supraphysiological temperatures. - Biophys. J., 68, 2608-2614, 1995.
88. Moulin M., Arrigo A.-P. - Long lasting heat shock stimulation of TRAIL-induced apoptosis in transformed T lymphocytes. - Exp. Cell Res., 312, 1765-1784, 2006.
89. Dynlacht J.R., Fox M.H. - Effects of hyperthermia and membrane-active compounds or low pH on the membrane fluidity of chinese hamster ovary cells. - Int. J. Hyperthermia, 8, 351-362, 1992.
90. Moulin M., Carpentier S., Levade T., Arrigo A.-P. - Potential roles of membrane fluidity and ceramide in hyperthermia and alcohol stimulation of TRAIL apoptosis. - Apoptosis, 12, 1703-1720, 2007.
91. Nishida T., Akagi K., Tanaka Y. - Correlation between cell killing effect and cell membrane potential after heat treatment: analysis using fluorescent dye and flow cytometry. - Int. J. Hyperthermia, 13, 227-234, 1997.
92. Wachsberger P.R., Coss R.A. - Effects of hyperthermia on the cytoskeleton and cell survival in G1 and S phase chinese hamster ovary cells. - Int. J. Hyperthermia, 6, 67-85, 1990.
93. Luchetti F., Burattini S., Ferri P., Papa S., Falcieri E. - Actin involvement in apoptotic chromatin changes of hemopoietic cells undergoing hyperthermia. - Apoptosis, 7, 143-152, 2002.
94. Lim C.-U., Zhang Y., Fox M.H. - Cell cycle dependent apoptosis and cell cycle blocks induced by hyperthermia in HL-60 cells. - Int. J. Hyperthermia, 22, 77-91, 2006.
95. Mondovi B., Strom R., Rotilio G., Agro A.F., Cavaliere R., Fanelli A.R. - The biochemical mechanism of selective heat sensitivity of cancer cells: I. Studies on cellular respiration. - Eur. J. Cancer, 5, 129-136, 1969.
96. Coss R.A., Storck C.W., Daskalakis C., Berd D., Wahl M.L. - Intracellular acidification abrogates the heat shock response and compromises survival of human melanoma cells. - Mol. Cancer Ther., 2, 383-388, 2003.
97. Will O., Mahler H.C., Arrigo A.P., Epe B. - Influence of glutathione levels and heat-shock on the steady-state levels of oxidative DNA base modifications in mammalian cells. - Carcinog., 20, 333-337, 1999.
98. Skibba J.L., Quebbeman E.J., Kalbfleisch J.H. - Nitrogen metabolism and lipid peroxidation during hyperthermic perfusion of human livers with cancer. - Cancer Res., 46, 6000-6003, 1986.
99. Yoshikawa T., Kokura S., Tainaka K., Itani K., Oyamada H., Kaneko T., Naito Y., Kondo M. - The role of active oxygen species and lipid peroxidation in the antitumor effect of hyperthermia. - Cancer Res., 53, 2326-2329, 1993.
100. Loven D.P., Leeper D.B., Oberley L.W. - Superoxide dismutase levels in chinese hamster ovary cells and ovarian carcinoma cells after hyperthermia or exposure to cycloheximide. - Cancer Res., 45, 3029-3033, 1985.
101. Lin P.S., Quamo S., Ho K.C., Gladding J. - Hyperthermia enhances the cytotoxic effects of reactive oxygen species to chinese hamster cells and bovine endothelial cells in vitro. - Radiat. Res., 126, 43-51, 1991.
102. Powers R.H., Stadnicka A., Kalbfleish J.H., Skibba J.L. - Involvement of xanthine oxidase in oxidative stress and iron release during hyperthermic rat liver perfusion. - Cancer Res., 52, 1699-1703, 1992.
103. Skibba J.L., Gwartney E.A. - Liver hyperthermia and oxidative stress: role of iron and aldehyde production. - Int. J. Hyperthermia, 13, 215-226, 1997.
104. Turano C., Ferraro A., Strom R., Cavaliere R., Fanelli A.R. - The biochemical mechanism of selective heat sensitivity of cancer cells: III. Studies on lysosomes. - Eur. J. Cancer, 6, 67-72, 1970.
105. Lepock J.R. - Role of nuclear protein denaturation and aggregation in thermal radiosensitization. - Int. J. Hyperthermia, 20, 115-130, 2004.
106. Kampinga H.H., Turkeluygur N., Roti J.L.R., Konings A.W.T. - The relationship of increased nuclear protein content induced by hyperthermia to killing of HeLa S3 cells. - Radiat. Res., 117, 511-522, 1989.
107. Strom H., Santoro A.S., Crifo C., Bozzi A., Mondovi B., Fanelli A.R. - The biochemical mechanism of selective heat sensitivity of cancer cells: IV. Inhibition of RNA synthesis. - Eur. J. Cancer, 9, 103-112, 1973.
108. Mondovi B., Agro A.F., Rotilio G., Strom R., Moricca G., Fanelli A.R. - The biochemical mechanism of selective heat sensitivity of cancer cells: II. Studies on nucleic acids and protein synthesis. - Eur. J. Cancer, 5, 137-146, 1969.
109. Henle K.J., Leeper D.B. - Effects of hyperthermia (45°C) on macromolecular synthesis in chinese hamster ovary cells. - Cancer Res., 39, 2665-2674, 1979.
110. rd ed. - J. Therm. Biol., 28, 75-106, 2003.
111. Agashe V.R., Hartl F.U. - Roles of molecular chaperones in cytoplasmic protein folding. - Semin. Cell Dev. Biol., 11, 15-25, 2000.
112. William J W. - The role of heat-shock proteins as molecular chaperones. - Curr. Opin. Cell Biol., 3, 1033-1038, 1991.
113. Yon J.M., Betton J.-M. - Protein folding in vitro and in the cellular environment. - Biol. Cell, 71, 17-23, 1991.
114. Ahsen, Pfanner - Molecular chaperones: towards a characterization of the heat-shock protein 70 family. - Trends Cell Biol., 7, 129-133, 1997.
115. Jäättelä M. - Heat shock proteins as cellular lifeguards. - Ann. Med., 31, 261-271, 1999.
116. Morimoto R.I. - Cells in stress: transcriptional activation of heat shock genes. - Sci., 259, 1409-1410, 1993.
117. Reiter T., Penman S. - Prompt heat shock proteins: translationally regulated synthesis of new proteins associated with the nuclear matrix-intermediate filaments as an early response to heat shock. - Proc. Natl Acad., 80, 74737-4741, 1983.
118. Subjeck J.R., Sciandra J.J., Johnson R.J. - Heat-shock proteins and thermotolerance - a comparison of induction kinetics. - Br. J. Radiol., 55, 579-584, 1982.
119. Landry J., Bernier D., Chrétien P., Nicole L.M., Tanguay R.M., Marceau N. - Synthesis and degradation of heat shock proteins during development and decay of thermotolerance. - Cancer Res., 42, 2457-2461, 1982.
120. Li G.C., Werb Z. - Correlation between synthesis of heat shock proteins and development of thermotolerance in chinese hamster fibroblasts. - Proc. Natl. Acad. Sci. USA, 79, 3218-3222, 1982.
121. Calderwood S.K., Theriault J.R., Gong J.L. - How is the immune response affected by hyperthermia and heat shock proteins? - Int. J. Hyperthermia, 21, 713-716, 2005.
122. Pandya M.J., Bendz H., Manzenrieder F., Noessner E., Kessler H., Buchner J., Issels R.D. - Interaction of human heat shock protein 70 with tumor-associated peptides. - Biol. Chem., 390, 305-312, 2009.
123. Multhoff G. - Activation of natural killer cells by heat shock protein 70. - Int. J. Hyperthermia, 25, 169-175, 2009.
124. Multhoff G. - Heat shock protein 72 (HSP72), hyperthermia-inducible immunogenic determinant on leukemic K562 and Ewing's sarcoma cells. - Int. J. Hyperthermia, 13, 39-48, 1997.
125. Pockley A.G. - Heat shock proteins as regulators of the immune response. - The Lancet, 362, 469-476, 2003.
126. Torigoe T., Tamura Y., Sato N. - Heat shock proteins and immunity: application of hyperthermia for immunomodulation. - Int. J. Hyperthermia, 25, 610-616, 2009.
127. Wells A.D., Malkovsky M. - Heat shock proteins, tumor immunogenicity and antigen presentation: an integrated view. - Immunol. Today, 21, 129-132, 2000.
128. Multhoff G., Botzler C., Wiesnet M., Eissner G., Issels R. - CD3- large granular lymphocytes recognize a heat-inducible immunogenic determinant associated with the 72-kD heat shock protein on human sarcoma cells. - Blood, 86, 1374-1382, 1995.
129. Gabriele M. - Heat shock protein 70 (Hsp70):membrane location, export and immunological relevance. - Methods, 43, 229-237, 2007.
130. Cippitelli M., Fionda C., Di Bona D., Piccoli M., Frati L., Santoni A. - Hyperthermia enhances CD95-ligand gene expression in T lymphocytes. - J. Immunol., 174, 223-232, 2005.
131. Muthana M., Multhoff G., Graham Pockley A. - Tumour infiltrating host cells and their significance for hyperthermia. - Int. J. Hyperthermia, 26, 247-255, 2010.
132. Knippertz I., Stein M.F., Doerrie J., Schaft N., Mueller I., Deinzer A., Steinkasserer A., Nettelbeck D.M. - Mild hyperthermia enhances human monocyte-derived dendritic cell functions and offers potential for applications in vaccination strategies. - Int. J. Hyperthermia, 27, 591-603, 2011.
133. Mace T.A., Zhong L., Kokolus K.M., Repasky E.A. - Effector CD8+ T cell IFN-γ production and cytotoxicity are enhanced by mild hyperthermia. - Int. J. Hyperthermia, 28, 9-18, 2012.
134. Mace T.A., Zhong L., Kilpatrick C., Zynda E., Lee C.-T., Capitano M., Minderman H., Repasky E.A. - Differentiation of CD8+ T cells into effector cells is enhanced by physiological range hyperthermia. - J. Leukoc. Biol., 90, 951-962, 2011.
135. Beachy S.H., Repasky E.A. - Toward establishment of temperature thresholds for immunological impact of heat exposure in humans. - Int. J. Hyperthermia, 27, 344-352, 2011.
136. Vaupel P., Kallinowski F., Okunieff P. - Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. - Cancer Res., 49, 6449-6465, 1989.
137. Vaupel P. - Tumor microenvironmental physiology and its implications for radiation oncology. - Semin. Radiat. Oncol., 14, 198-206, 2004.
138. Vaupel P. - Tumor blood flow. - In: Blood Perfusion and Microenvironment of Human Tumors: Implications for Clinical Radiooncology, M. Molls, P. Vaupel Eds., Springer-Verlag, Berlin-Heidelberg-New York, 2000, p. 41-45.
139. Vaupel P.W., Kelleher D.K. - Pathophysiological and vascular characteristics of tumours and their importance for hyperthermia: heterogeneity is the key issue. - Int. J. Hyperthermia, 26, 211-223, 2010.
140. Song C.W. - Modification of blood flow. - In: Blood Perfusion and Microenvironment of Human Tumors: Implications for Clinical Radiooncology, M. Molls, R Vaupel Eds., Springer-Verlag, Berlin-Heidelberg-New York, 2000, p. 193-207.
141. Fajardo L.F., Prionas S.D. - Endothelial cells and hyperthermia. - Int. J. Hyperthermia, 10, 347-353, 1994.
142. Brown S.L., Hunt J.W., Hill R.P. - Differential thermal sensitivity of tumour and normal tissue microvascular response during hyperthermia. - Int. J. Hyperthermia, 8, 501-514, 1992.
143. Sawaji Y., Sato T., Takeuchi A., Hirata M., Ito A. - Anti-angiogenic action of hyperthermia by suppressing gene expression and production of tumour-derived vascular endothelial growth factor in vivo and in vitro. - Br. J. Cancer, 86, 1597-1603, 2002.
144. Matthew C.B., DuBose D.A., Sils I.V., Tartartini K.A. - Hyperthermia-induced changes in the vascular permeability of rats: a model system to examine therapeutic interventions. - J. Therm. Biol., 25, 381-386, 2000.
145. Dings R.P.M., Loren M.L., Zhang Y., Mikkelson S., Mayo K.H., Corry P., Griffin R.J. - Tumour thermotolerance, a physiological phenomenon involving vessel normalisation. - Int. J. Hyperthermia, 27, 42-52, 2011.
146. Vaupel P., Höckel M. - Oxygenation of human tumors. - In: Blood Perfusion and Microenvironmentof Human Tumors: Implications for Clinical Radiooncology, M. Molls, P. Vaupel Eds., Springer Verlag, Berlin-Heidelberg-New York, 2000, p. 63-72.
147. Song C.W., Park H.J., Lee C.K., Griffin R. - Implications of increased tumor blood flow and oxygenation caused by mild temperature hyperthermia in tumor treatment. - Int. J. Hyperthermia, 21, 761-767, 2005.
148. Song C.W., Shakil A., Osborn J.L., Iwata K. - Tumour oxygenation is increased by hyperthermia at mild temperatures. - Int. J. Hyperthermia, 25, 91-95, 2009.
149. Stubbs M. - Tumour pH - In: Blood Perfusion and Microenvironment of Human Tumors: Implications for Clinical Radiooncology, M. Molls, P. Vaupel Eds., Springer-Verlag, Berlin-Heidelberg-New York, 2000, p. 113-120.
150. Mohamed F., Marchettini P., Stuart O.A., Urano M., Sugarbaker P.H. - Thermal enhancement of new chemotherapeutic agents at moderate hyperthermia. - Ann. Surg. Oncol., 10, 463-468, 2003.
151. Matsuoka H., Abe R., Furusawa M., Tomoda H., Seo Y., Sugimachi K. - Increased uptake and prolonged retention of actinomycin D by concomitant hyperthermia related to cytotoxic enhancement. - Int. J. Hyperthermia, 9, 403-413, 1993.
152. Mohamed F., Stuart O.A., Glehen O. - Docetaxel and hyperthermia: factors that modify thermal enhancement. - J. Surg. Oncol., 88, 14-20, 2004.
153. Bull J.M.C., Strebel F.R., Jenkins G.N., Deng W., Rowe R.W. - The importance of schedule in whole body thermochemotherapy. - Int. J. Hyperthermia, 24, 171-181, 2008.
154. Schopman E.M., Van Bree C., Bakker P.J.M., Kipp J.B.A., Barendsen G.W. - Hyperthermia-enhanced effectiveness of mitoxantrone in an experimental rat tumour. - Int. J. Hyperthermia, 12, 241-254, 1996.
155. Hildebrandt B., Wust P. - Interactions between hyperthermia and cytotoxic drugs. - Cancer Treat. Res., 134, 185-193, 2007.
156. Urano M. - For the clinical application of thermochemotherapy given at mild temperatures. - Int. J. Hyperthermia, 15, 79-107, 1999.
157. Pennacchioli E., Fiore M., Gronchi A. - Hyperthermia as an adjunctive treatment for soft-tissue sarcoma. - Expert Rev. Anticancer Ther., 9, 199-210, 2009.
158. Hildebrandt B., Hegewisch-Becker S., Kerner T., Nierhaus A., Bakhshandeh-Bath A., Janni W., Zumschlinge R., Sommer H., Riess H., Wust P. - Current status of radiant whole-body hyperthermia at temperatures >41.5°C and practical guidelines for the treatment of adults. The German 'Interdisciplinary Working Group on Hyperthermia'. - Int. J. Hyperthermia, 21, 169-183, 2005.
159. Jones E., Alvarez Secord A., Prosnitz L.R., Samulski T.V., Oleson J.R., Berchuck A., Clarke-Pearson D., Soper J., Dewhirst M.W., Vujaskovic Z. - Intra-peritoneal cisplatin and whole abdomen hyperthermia for relapsed ovarian carcinoma. - Int. J. Hyperthermia, 22, 161-172, 2006.
160. Alvarez Secord A., Jones E.L., Hahn C.A., Petros W.P., Yu D., Havrilesky L.J., Soper J.T., Berchuck A., Spasojevic I., Clarke-Pearson D.L., Prosnitz L.R., Dewhirst M.W. - Phase I/II trial of intravenous Doxil and whole abdomen hyperthermia in patients with refractory ovarian cancer. - Int. J. Hyperthermia, 21, 333-347, 2005.
161. Dahl O. - Status of clinical hyperthermia. - Acta Oncol., 38, 863-873, 1999.
162. Jones E.L., Samulski T.V., Dewhirst M.W., Alvarez Secord A., Berchuck A., Clarke-Pearson D., Havrilesky L.J., Soper J., Prosnitz L.R. - A pilot phase II trial of concurrent radiotherapy, chemotherapy, and hyperthermia for locally advanced cervical carcinoma. - Cancer, 98, 277-282, 2003.
163. Clemens M.W., Sultan A.R., Matthaus K. - Response to neoadjuvant chemotherapy combined with regional hyperthermia predicts long-term survival for adult patients with retroperitoneal and visceral high-risk soft tissue sarcomas. - J. Clin. Oncol., 20, 3156-3164, 2002.
164. Issels R.D., Abdel-Rahman S., Wendtner C.M., Falk M.H., Kurze V., Sauer H., Aydemir U., Hiddemann W. - Neoadjuvant chemotherapy combined with regional hyperthermia (RHT) for locally advanced primary or recurrent high-risk adult soft-tissue sarcomas (STS) of adults: long-term results of a phase II study. - Eur. J. Cancer, 37, 1599-1608, 2001.
165. Maeta M., Kaibara N., Nakashima K., Kobayashi M., Yoshikawa T., Okamoto A., Sugiyama A. - A case-matched control study of intrahepatoarterial chemotherapy in combination with or without regional hyperthermia for treatment of primary and metastatic hepatic-tumors. - Int. J. Hyperthermia, 10, 51-58, 1994.
166. Hamazoe R., Maeta M., Kaibara N. - Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer. - Cancer, 73, 2048-2052, 1994.
167. Atallah D., Marsaud V., Radanyi C., Kornprobst M., Rouzier R., Elias D., Renoir J.-M. - Thermal enhancement of oxaliplatin induced inhibition of cell proliferation and cell cycle progression in human carcinoma cell lines. - Int. J. Hyperthermia, 20, 405-419, 2004.
168. Hahn G.M., Braun J., Har-Kedar I. - Thermochemotherapy: synergism between hyperthermia (42-43°C) and adriamycin (or bleomycin) in mammalian cell inactivation. - Proc. Natl. Acad. Sci. USA, 72, 937-940, 1975.
169. Nakao K., Otsuki Y., Akao Y., Ito Y., Marukawa O., Tachibana S., Kawakami M., Sasaki S. - The synergistic effects of hyperthermia and anticancer drugs on induction of apoptosis. - Med. Electron Microsc., 33, 44-50, 2000.
170. Cividalli A., Livdi E., Ceciarelli F., Piscitelli M., Pasqualetti P., Cruciani G., Danesi D.T. - Hyperthermia and paclitaxel-epirubicin chemotherapy: enhanced cytotoxic effect in a murine mammary adenocarcinoma. - Int. J. Hyperthermia, 16, 61-71, 2000.
171. Cividalli A., Cruciani G., Livdi E., Pasqualetti P., Danesi D.T. - Hyperthermia enhances the response of paclitaxel and radiation in a mouse adenocarcinoma. - Int. J. Radiat. Oncol. Biol. Phys., 44, 407-412, 1999.
172. Calcagno A.M. - Evolution of drug resistance in cancer: the emergence of unique mechanisms and novel techniques. - Mol. Pharm., 8, 1993-1993, 2011.
173. Wang C.Y., Cusack J.C., Liu R., Baldwin AS. - Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-κB. - Nat. Med., 5, 412-417, 1999.
174. Adachi S., Kokura S., Okayama T., Ishikawa T., Takagi T., Handa O., Naito Y., Yoshikawa T. - Effect of hyperthermia combined with gemcitabine on apoptotic cell death in cultured human pancreatic cancer cell lines. - Int. J. Hyperthermia, 25, 210-219, 2009.
175. Averill D.A., Larrivée B. - Hyperthermia, cyclosporine A and melphalan cytotoxicity and transport in multidrug resistant cells. - Int. J. Hyperthermia, 14, 583-588, 1998.
176. Hettinga J.V.E., Konings A.W.T., Kampinga H.H. - Reduction of cellular
177. Konings A.W.T., Hettinga J.V.E., Lemstra W., Humphrey G.B., Kampinga H.H. - Sensitizing for cis-diamminedichloroplatinum(II) action by hyperthermia in resistant cells. - Int. J. Hyperthermia, 9, 553-562, 1993.
178. Ković L.B.-O., Jakŝić M., Oreŝković S., Osmak M. - Hyperthermic modulation of resistance to cis-diammine- dichloroplatinum(II) in human larynx carcinoma cells. - Int. J. Hyperthermia, 13, 205-214, 1997.
179. Eichholtz-Wirth H., Hietel B. - Heat sensitization to cisplatin in two cell lines with different drug sensitivities. - Int. J. Hyperthermia, 6, 47-55, 1990.
180. Van Bree C., Franken N.A.P., Snel F.A.M., Haveman J., Bakker P.J.M. - Wild-type p53-function is not required for hyperthermia enhanced cytotoxicity of cisplatin. - Int. J. Hyperthermia, 17, 337-346, 2001.
181. Dahl O., Mella O. - Referee: hyperthermia alone or combined with cisplatin in addition to radiotherapy for advanced uterine cervical cancer. - Int. J. Hyperthermia, 18, 25-30, 2002.
182. Bergs J.W.J., Franken N.A.P., Haveman J., Geijsen E.D., Crezee J., van B.C. -Hyperthermia, cisplatin and radiation trimodality treatment: a promising cancer treatment? A review from preclinical studies to clinical application. - Int. J. Hyperthermia, 23, 329-341, 2007.
183. Franckena M., De W.R., Ansink A.C., Notenboom A., Canters R.A.M., Fatehi D., Van R.G.C., Van D.Z.J. - Weekly systemic cisplatin plus locoregional hyperthermia: an effective treatment for patients with recurrent cervical carcinoma in a previously irradiated area. - Int. J. Hyperthermia, 23, 443-450, 2007.
184. Shen H., Li X.-D., Wu C.-P., Yin Y.-M., Wang R.-s., Shu Y.-Q. - The regimen of gemcitabine and cisplatin combined with radio frequency hyperthermia for advanced non-small cell lung cancer: a phase II study. - Int. J. Hyperthermia, 27, 27-32, 2011.
185. Purushotham S., Ramanujan R.V. - Thermoresponsive magnetic composite nanomaterials for multimodal cancer therapy. - Acta Biomater., 6, 502-510, 2010.
186. Purushotham S., Ramanujan R.V. - Modeling the performance of magnetic nanoparticles in multimodal cancer therapy. - J. Appl. Phys., 107, 1-9, 2010.
187. Chang J., Rumpel H., Kee H.C.I., Goh L.H.A., Ng T.H.R., Chow K.H P., Ramanujan R.V., Tan C.K. - Novel therapeutics in hepatocellular carcinoma-targeted hyperthermia treatment and drug release using superparamagnetic iron oxide nanoparticles. - J. Hepatol., 46, S103-S103, 2007.
188. Babincova M., Altanerova V., Altaner C., Bergemann C., Babinec P. - In vitro analysis of cisplatin functionalized magnetic nanoparticles in combined cancer chemotherapy and electromagnetic hyperthermia. - IEEE Trans. Nanobiosci., 7, 15-19, 2008.
189. Mahmoudi M., Sant S., Wang B., Laurent S., Sen T. - Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy. - Adv. Drug Deliv. Rev., in press, 2011.
190. Galibert P., Deramond H., Rosat P., Le Gars D. - Preliminary note on the treatment of vertebral angioma by percutaneous acrylic vertebroplasty. - Neurochir., 33, 166-168, 1987.
191. Galibert P., Deramond H., Rosat P., Legars D. - A treatment method for certain spinal angiomas - percutaneous vertebroplasty with acrylic cement. - Neurochir., 33, 166-168, 1987.
192. Guglielmi G., Andreula C., Muto M., Gilula L.A. - Percutaneous vertebroplasty: indications, contraindications, technique, and complications. - Acta Radiol., 46, 256-268, 2005.
193. Yang H., Zou J. - Filling materials used in kyphoplasty and vertebroplasty for vertebral compression fracture: a literature review. - Artif. Cells, Blood Substit., and Biotechnol., 39, 87-91, 2011.
194. Denaro L., Longo U.G., Denaro V. - Vertebroplasty and kyphoplasty: reasons for concern? - Orthop. Clin. North Am., 40, 465-+, 2009.
195. Anselmetti G., Manca A., Kanika K., Murphy K., Eminefendic H., Masala S., Regge D. - Temperature measurement during polymerization of bone cement in percutaneous vertebroplasty: an in vivo study in humans. - Cardiovasc. Intervent. Radiol., 32, 491-498, 2009.
196. Bhatia D. - Bone cement: the new medical quick fix. - Chron. Young Sci., 1, 1-4, 2010.
197. Bohner M. - Reactivity of calcium phosphate cements. - J. Mater. Chem., 17, 3980-3986, 2007.
198. Dorozhkin S. - Calcium orthophosphates in nature, biology and medicine. - Mater., 2, 399-498, 2009.
199. Juhasz J., Best S. - Bioactive ceramics: processing, structures and properties. - J. Mater. Sci., 47, 610-624, 2012.
200. Bose S., Tarafder S., Edgington J., Bandyopadhyay A. - Calcium phosphate ceramics in drug delivery. - J. Miner. Met. Mater. Soc., 63, 93-98, 2011.
201. Lewis G. - Injectable bone cements for use in vertebroplasty and kyphoplasty: state-of-the-art review. - J. Biomed. Mater. Res. Appl. Biomater., 76B, 456-468, 2006.
202. Nandi S.K., Mukherjee P., Roy S., Kundu B., De D.K., Basu D. - Local antibiotic delivery systems for the treatment of osteomyelitis - a review. - Mater. Sci. Eng. C, 29, 2478-2485, 2009.
203. Hofmann A.A., Goldberg T., Tanner A.M., Kurtin S.M. - Treatment of infected total knee arthroplasty using an articulating spacer. - Clin. Orthop. Relat. Res., 430, 125-131, 2005.
204. Madanagopal S.G., Seligson D., Roberts C.S. - The antibiotic cement nail for infection after tibial nailing. - Orthop., 27, 709-712, 2004.
205. Froschle G.W., Mahlitz J., Langendorff H.U., Achilles E., Pollock J., Jungbluth K.H. - Release of daunorubicin from polymethylmethacrylate for the improvement of the local growth control of bone metastasis animal experiments. - Anticancer Res., 17, 995-1002, 1997.
206. Hernigou P., Thiery J.P., Benoit J., Voisin M.C., Leroux P., Hagege G., Delepine G., Goutallier D. - Methotrexate diffusion from acrylic cement - local chemotherapy for bone-tumors. - J. Bone Joint Surg. Br., 71, 804-811, 1989.
207. Kim H.S., Park Y.B., Oh J.H., Yoo K.H., Lee S.H. - The cytotoxic effect of methotrexate loaded bone cement on osteosarcoma cell lines. - Int. Orthop., 25, 343-348, 2001.
208. Maccauro G., Cittadini A., Casarci M., Muratori F., De Angelis D., Piconi C., Rosa M.A., Spadoni A., Braden M., Sgambato A. - Methotrexate-added acrylic cement: biological and physical properties. - J. Mater. Sci. Mater. Med., 18, 839-844, 2007.
209. Handal J.A., Frisch R.F., Weaver W.L., Williams E.A., Dimatteo D. - Method for the physical analysis of drug-bone cement composite. - Clin. Orthop. Relat. Res., 459, 105-109, 2007.
210. Handal J.A., Schulz J.F., Pahys J.M., Williams E.A., Kwok S.C.M., Samuel S.P. -Evaluation of elution and mechanical properties of two injectable chemotherapeutic bone cements. - Chemother., 57, 268-274, 2011.
211. Healey J.H., Shannon F., Boland P., DiResta G.R. - PMMA to stabilize bone and deliver antineoplastic and antiresorptive agents. - Clin. Orthop. Relat. Res., 415S, S263-S275, 2003.
212. Wang H.M., Crank S., Oliver G., Galasko C.S.B. - The effect of methotrexate-loaded bone cement on local destruction by the VX2 tumour. - J. Bone Joint Surg. Br., 78B, 14-17, 1996.
213. Wang H.M., Galasko C.S.B., Crank S., Oliver G., Ward C.A. - Methotrexate loaded acrylic cement in the management of skeletal metastases - biomechanical, biological and systemic effect. - Clin. Orthop. Relat. Res., 312, 173-186, 1995.
214. Savadkoohi D.G., Sadeghipour P., Attarian H., Sardari S., Eslamifar A., Shokrgozar M.A. - Cytotoxic effect of drugs eluted from polymethylmethacrylate on stromal giant-cell tumour cells. - J. Bone Joint Surg. Br., 90B, 973-979, 2008.
215. Rosa M.A., Maccauro G., Sgambato A., Ardito R., Falcone G., De Santis V., Muratori F. - Acrylic cement added with antiblastics in the treatment of bone metastases - ultrastructural and in vitro analysis. - J. Bone Joint Surg. Br., 85B, 71 2-716, 2003.
216. Greco F., Depalma L., Specchia N., Jacobelli S., Gaggini C. - Polymethylmethacrylate-antiblastic drug compounds: an in vitro study assessing the cytotoxic effect in cancer cell lines - a new method for local chemotherapy of bone metastasis. - Orthop., 15, 189-194, 1992.
217. Zwolak P., Manivel J.C., Jasinski P., Kirstein M.N., Dudek A.Z., Fisher J., Cheng E.Y. - Cytotoxic effect of zoledronic acid-loaded bone cement on giant cell tumor, multiple myeloma, and renal cell carcinoma cell lines. - J. Bone Joint Surg. Am., 92A, 162-168, 2010.
218. Tani T., Okada K., Takahashi S., Suzuki N., Shimada Y., Itoi E. - Doxorubicin-loaded calcium phosphate cement in the management of bone and soft tissue tumors. - In vivo, 20, 55-60, 2006.
219. Lopez-Heredia M.A., Bernard Kamphuis G.J., Thüne P.C., Cumhur Öner F., Jansen J.A., Frank Walboomers X. - An injectable calcium phosphate cement for the local delivery of paclitaxel to bone. - Biomater., 32, 5411-5416, 2011.
220. Tanzawa Y., Tsuchiya H., Shirai T., Nishida H., Hayashi K., Takeuchi A., Kawahara M., Tomita K. - Potentiation of the antitumor effect of calcium phosphate cement containing anticancer drug and caffeine on rat osteosarcoma. - J. Orthop. Sci., 16, 77-84, 2011.
221. Tahara Y., Ishii Y. - Apatite cement containing cis- diamminedichloroplatinum implanted in rabbit femur for sustained release of the anticancer drug and bone formation. - J. Orthop. Sci., 6, 556-565, 2001.
222. Vechasilp J., Tangtrakulwanich B., Oungbho K., Yuenyongsawad S. - The efficacy of methotrexate-impregnated hydroxyapatite composites on human mammary carcinoma cells. - J. Orthop. Surg., 15, 56-61, 2007.
223. Kawashita M., Kawamura K., Li Z. - PMMA-based bone cements containing magnetite particles for the hyperthermia of cancer. - Acta Biomater., 6, 3187-3192, 2010.
224. Matsumine A., Kusuzaki K., Matsubara T., Shintani K., Satonaka H., Wakabayashi T., Miyazaki S., Morita K., Takegami K., Uchida A. - Novel hyperthermia for metastatic bone tumors with magnetic materials by generating an alternating electromagnetic field. - Clin. Exp. Metastasis, 24, 191-200, 2007.
225. Kusaka M., Takegami K., Sudo A., Yamazaki T., Kawamura J., Uchida A. - Effect of hyperthermia by magnetite cement on tumor-induced bone destruction. - J. Orthop. Sci., 7, 354-357, 2002.
226. Takegami K., Sano T., Wakabayashi H., Sonoda J., Yamazaki T., Morita S., Shibuya T., Uchida A. - New ferromagnetic bone cement for local hyperthermia. - J. Biomed. Mater. Res., 43, 210-214, 1998.
227. Ohura K., Ikenaga M., Nakamura T., Yamamuro T., Ebisawa Y., Kokubo T., Kotoura Y., Oka M. - A heat-generating bioactive glass-ceramic for hyperthermia. - J. Appl. Biomater., 2, 153-159, 1991.
228. Bretcanu O., Spriano S., Vitale C.B., Verne E. - Synthesis and characterization of coprecipitation-derived ferrimagnetic glass-ceramic. - J. Mater. Sci., 41, 1029-1037, 2006.
229. Ebisawa Y., Miyaji F., Kokubo T., Ohura K., Nakamura T. - Bioactivity of ferrimagnetic glass-ceramics in the system FeO-Fe2O3-CaO-SiO2. - Biomater., 18, 1277-1284, 1997.
230. Portela A., Vasconcelos M., Branco R., Gartner F., Faria M., Cavalheiro J. - An in vitro and in vivo investigation of the biological behavior of a ferrimagnetic cement for highly focalized thermotherapy. - J. Mater. Sci. Mater. Med., 21, 2413-2423, 2010.
231. Luderer A.A., Borrelli N.F., Panzarino J.N., Mansfield G.R., Hess D.M., Brown J.L., Barnett E.H., Hahn E.W. - Glass-ceramic-mediated, magnetic-field-induced localized hyperthermia: response of a murine mammary carcinoma. - Radiat. Res., 94, 190-198, 1983.
232. th Annual Meeting & Exposition of the Controlled Release Society, July 30-August 3, 2011, CRS Ed.